Amgen (AMGN) Cash & Equivalents (2009 - 2026)
Amgen (AMGN) reported Cash & Equivalents of $13.99 billion for Q2 2026, up 74.3% from $8.03 billion a year earlier and up 16.2% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Amgen posted Cash & Equivalents of $9.13 billion, down 23.8% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $11.97 billion in FY2024 (+9.4%), $10.94 billion in FY2023 (+43.5%), $7.63 billion in FY2022 (-4.5%) and $7.99 billion in FY2021 (+27.5%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q3 2023.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 0.5%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2023 (growth of 558.2%); the low point was Q3 2024 (a decline of 74.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12.04 billion (Q1 2026), $9.13 billion (Q4 2025) and $9.45 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 6.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.99 Bn |
| Mar 31, 2026 | 12.04 Bn |
| Dec 31, 2025 | 9.13 Bn |
| Sep 30, 2025 | 9.45 Bn |
| Jun 30, 2025 | 8.03 Bn |
| Mar 31, 2025 | 8.81 Bn |
| Dec 31, 2024 | 11.97 Bn |
| Sep 30, 2024 | 9.01 Bn |
| Jun 30, 2024 | 9.30 Bn |
| Mar 31, 2024 | 9.71 Bn |
| Dec 31, 2023 | 10.94 Bn |
| Sep 30, 2023 | 34.74 Bn |
| Jun 30, 2023 | 34.25 Bn |
| Mar 31, 2023 | 31.60 Bn |
| Dec 31, 2022 | 7.63 Bn |
| Sep 30, 2022 | 9.50 Bn |
| Jun 30, 2022 | 5.20 Bn |
| Mar 31, 2022 | 6.53 Bn |
| Dec 31, 2021 | 7.99 Bn |
| Sep 30, 2021 | 11.97 Bn |
API Access
Amgen Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();